// App-Quantinova.ai

11511 : Genomic analysis of circulating tumor DNA in 442 patients with carcinoma of unknown primary: Implications for targeted therapeutics.

Researchers

Presenter

  • Shumei Kato

Principal Investigators

  • Nithya Krishnamurthy

  • Kimberly Banks

  • Kirstin Anne Williams

  • Casey B. Williams

  • Brian Leyland-Jones

  • Richard B. Lanman

  • Razelle Kurzrock

Medical Centers

  • UCSD Moores Cancer Center, La Jolla, CA

  • Guardant Health, Rewdwood City, CA

  • Avera Cancer Institute, Sioux Falls, SD

  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, San Diego, CA

Locations

  • United States

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved